Author/Authors :
Shahryari، Gellare نويسنده Department of Biology, Faculty of Sciences, University of
Sistan and Baluchestan, Zahedan, IR Iran , , Shahraki، Ali نويسنده Department of Biology, Faculty of Sciences, University of
Sistan and Baluchestan, Zahedan, IR Iran , , Zakeri، Zahra نويسنده Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran Zakeri, Zahra
Abstract :
In some autoimmune diseases such as rheumatoid arthritis (RA), Interleukin-27 (IL-27) and IL-33 levels are increased. These observations suggest that IL-27 and IL-33 may have a role in the pathogenesis of polymyositis/dermatomyositis (PM/DM). The aim of this study was to assess IL-27 and IL-33 levels in PM/DM patients compared to healthy control subjects. Twenty patients with DM and nine patients with PM were recruited in this study. Twenty-nine healthy controls whose age and gender were matched with the patients were also recruited. Serum IL-27 and IL-33 was measured by the Enzyme-Linked Immunosorbent Assay (ELISA). The serum levels of IL-27 in patients with DM and PM were higher than those of healthy controls. There were no significant differences in serum levels of IL-33 in patients with DM and PM compared to the healthy control group. These data indicate that IL-27 might be selectively involved in the pathogenesis of DM and PM. However, IL-33 does not appear to be influenced
